The Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC) brings key members of the type 1 diabetes (T1D) community to together. We aim to accelerate the development and delivery of immunotherapy treatments that address the root cause of type 1 diabetes – immune system attack on insulin-p...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2022 (4 years)
Address:
9 PRINCES STREET; FITZROY, VICTORIA 3065, AU
LOW
spending power